Furthermore, MTT (Fig. 6a) and transwell functional assays (Fig. 6b, c) were used to detect whether GSK3β can reverse, at least in part, the impact of miR-452 on sustained CRC cell proliferation and migration. The gene discussed is GSK3B; the disease is colorectal carcinoma.